RecruitingPhase 1NCT06498713

Patient Controlled Administration of Liquid Acetaminophen

Patient Controlled Self-Administration of Oral Liquid Medication: Acetaminophen Trial


Sponsor

Yale University

Enrollment

24 participants

Start Date

Nov 19, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a proof of concept pilot study investigating the feasibility and acceptability of patient controlled oral medication administration, using the commonly used and low risk medication in the hospital, oral acetaminophen.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Acetaminophen 650 mg Oral Tablet, a drug called Acetaminophen 650mg Liquid, and others for people with pain and pain, postoperative. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAcetaminophen 650 mg Oral Tablet

650 mg pills

DRUGAcetaminophen 650mg Liquid

650 mg liquid

DEVICECADD pump

Primed and programmed to delivery 650 mg liquid acetaminophen into a medication cup every 4 hours as needed.


Locations(1)

Yale New Haven Hospital at St. Raphael's Campus

New Haven, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06498713


Related Trials